Suven Life Sciences Ltd. (SUVEN): Suven Life Sciences Ltd Share Price Hits Fresh 52-Week High at Rs 392.05

Published: 24 August 2026 at 10:48 AM IST

Suven Life Sciences Share Price moved to Rs 392.05 on 24 August 2026, up 5.28% from the previous close of Rs 372.4, and set a fresh 52-week high of Rs 393. The company’s market capitalisation stands at Rs 10,522.63 crore. This Suven Life Sciences Share Price Today update confirms a new yearly high for SUVEN, while the supplied data does not establish a company-specific catalyst. Suven Life Sciences Stock News is therefore centered on the price event, the day’s range and the valuation context rather than an unverified trigger. For Univest readers, the move is relevant because it combines a fresh high with a sizeable listed-company valuation and a sector backdrop that can be compared against peers in Pharmaceuticals & Drugs.

Suven Life Sciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 392.05
Previous Close	Rs 372.4
Today's Move	+Rs 19.65 (+5.28%)
Open	Rs 375.75
High	Rs 393
Low	Rs 366.65
Turnover	Rs 2.88 crore
Market Capitalisation	Rs 10,522.63 crore

Suven Life Sciences Ltd. (SUVEN) traded at Rs 392.05 versus the previous close of Rs 372.4, a rise of 5.28%. The stock opened at Rs 375.75, reached a high of Rs 393 and touched a low of Rs 366.65.

Suven Life Sciences Share Price Today opened at Rs 375.75, moved between Rs 366.65 and Rs 393, and finished at Rs 392.05. The gain of Rs 19.65 versus the previous close of Rs 372.4 reflects the day’s 5.28% advance. The fresh 52-week high of Rs 393 was matched by the day’s high, which places the stock just below that level at the close. Turnover stood at Rs 2.88 crore, giving a factual measure of traded value for the session. In simple event terms, SUVEN was one of the stocks in news for a price-led move into a one-year high zone. The data confirms the breakout-style price event, but it does not establish a company-specific cause. For Univest readers tracking Suven Life Sciences Share Price Live, the key watchpoint is whether the stock can continue holding near the fresh high area in the next sessions.

Suven Life Sciences Ltd. (SUVEN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 10,522.63 crore
P/B Ratio	18.89x
ROE	-101.8%
ROCE	-78.71%
EPS	Rs -12.47
Book Value Per Share	Rs 19.71
Dividend Yield	0%

Suven Life Sciences Ltd. (SUVEN) fundamental metrics show P/B 18.89x, ROE -101.8%, ROCE -78.71%. These figures provide context only and are not a buy or sell signal.

Suven Life Sciences Ltd. has a market capitalisation of Rs 10522.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/B at 18.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.9x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	30.9x
Benchmark Average P/E	46.33x
Benchmark P/E Range	2.94x to 689.27x
Company P/B Ratio	18.89x
Benchmark Median P/B	2.57x
Company ROE	-101.8%
Benchmark Median ROE	11.81%
Company ROCE	-78.71%
Benchmark Median ROCE	13.68%
Company Market Capitalisation	Rs 10,522.63 crore
Benchmark Median Market Cap	Rs 506.13 crore

Suven Life Sciences Ltd. (SUVEN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Suven Life Sciences Ltd. (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.81%, a difference of -961.98%. Suven Life Sciences Ltd. (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.68%, a difference of -675.37%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Blue Jet Healthcare Ltd.	BLUEJET	11,282.72	48.03	5.04	19.88	27.18
Sanofi Consumer Healthcare India Ltd.	SANOFICONR	9,714.89	36.52	27.92	73.2	98.11
Procter & Gamble Health Ltd.	PGHL	9,684.91	27.14	15.73	62.18	84.86
Akums Drugs & Pharmaceuticals Ltd.	AKUMS	11,804.55	40.46	3.46	8.06	14.77
Sequent Scientific Ltd.	VIYASH	12,152.45	71	4.32	9.06	13.1

Its ROE of -101.8% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Suven Life Sciences Ltd. (SUVEN) has a market capitalisation of Rs 10,522.63 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Suven Life Sciences

• Suven Life Sciences Share Price hit a fresh 52-week high of Rs 393 and closed at Rs 392.05.
• The stock rose Rs 19.65, or 5.28%, versus the previous close of Rs 372.4.
• Turnover for the session was Rs 2.88 crore.
• Market capitalisation is Rs 10,522.63 crore, with P/B at 18.89 and EPS at -12.47.
• Sector benchmarks show P/E at 49.93 for the company versus a median of 30.9 across the same industry.

About Suven Life Sciences

Suven Life Sciences Ltd. (SUVEN) operates in Healthcare and the Pharmaceuticals & Drugs industry. The company profile supplied for this Suven Life Sciences Stock News article focuses on market classification, financial measures and valuation context rather than a detailed business description. For Univest readers, that means the visible story around Suven Life Sciences Share Price is built from verified market data, sector benchmarks and reported financial ratios. The company’s current market capitalisation, book value per share, EPS, ROE and ROCE together frame the stock’s financial backdrop, while the fresh 52-week high keeps it in market discussion today.

Track Suven Life Sciences Share Price on Univest

Use Suven Life Sciences Ltd. (SUVEN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Suven Life Sciences Share Price on Univest for live updates, stock analysis, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare Suven Life Sciences Share Price Today with sector context, peer data and company financials in one place. You can use the platform to follow Suven Life Sciences Stock News, Suven Life Sciences Latest News and Suven Life Sciences Share Price Update as the market prints new levels.

Frequently Asked Questions

Why did Suven Life Sciences share price hit a fresh 52-week high?

Ans. The data confirms that Suven Life Sciences Share Price reached Rs 393, a fresh 52-week high, and closed at Rs 392.05. The supplied information does not establish a company-specific catalyst for the move.

What is Suven Life Sciences Share Price today?

Ans. Suven Life Sciences Share Price Today is Rs 392.05, up Rs 19.65 or 5.28% from the previous close of Rs 372.4. The session high was Rs 393, which also marks the fresh 52-week high.

What is the market capitalisation of Suven Life Sciences?

Ans. Suven Life Sciences has a market capitalisation of Rs 10,522.63 crore. This places the company above the same-industry median market cap of Rs 506.13 crore, though below the industry average of Rs 13,488.82 crore.

How does Suven Life Sciences look on valuation?

Ans. Suven Life Sciences Share Price is supported by a P/B ratio of 18.89, which is far above the sector median of 2.57. The stock also trades with negative ROE and ROCE, adding caution to valuation reading.

What do EPS and book value show for Suven Life Sciences?

Ans. EPS is -12.47 and book value per share is Rs 19.71. That means earnings remain negative while the accounting value per share is positive, which gives context to the current Suven Life Sciences Share Price.

Does Suven Life Sciences pay a dividend?

Ans. The supplied dividend yield for Suven Life Sciences is 0. That indicates no current yield in the data used for this Suven Life Sciences Share Price article, so the focus remains on price and financial metrics.

How does Suven Life Sciences compare with peers?

Ans. Compared with peers such as Blue Jet Healthcare, Sanofi Consumer Healthcare India and Procter & Gamble Health, Suven Life Sciences has weaker return ratios and a much higher P/B multiple. That shapes the peer view.

What does the sector benchmark show for Suven Life Sciences?

Ans. In the same industry, the benchmark P/E median is 30.9 and the company’s sector P/E is 49.93. The stock also sits well above the sector median P/B of 2.57, which matters for valuation context.

Where can investors track Suven Life Sciences Share Price live?

Ans. Investors can track Suven Life Sciences Share Price on Univest for live updates, fundamental ratios, shareholding pattern, 52-week levels and sector context. That keeps the price event, valuation and company data in one place.